UNRAVELLING THE COMPLEXITIES OF A GLOBAL EPIDEMIC: TECHNOLOGY, DIAGNOSIS AND TREATMENT OF DIABETES
Main Article Content
Keywords
Diabetes Epidemic, Technological Advancements, Diabetes Diagnosis, Diabetes Treatment, Continuous Glucose Monitoring, Artificial Intelligence in Healthcare, Personalized Treatment Plans, Telemedicine, Patient Engagement, Digital Health Platforms, Pharmacological Therapies, Lifestyle Interventions, Healthcare Innovation, Patient Education, Chronic Disease Management
Abstract
Background: The global diabetes epidemic presents a significant challenge, impacting millions of individuals and straining healthcare systems worldwide. This study aims to explore the complexities of diabetes management and the transformative impact of modern technology in diagnosing and treating the disease.
Objectives: To investigate the role of advancements in clinical devices, telemedicine, and personalized healthcare in the early detection and management of diabetes. Additionally, it examines the integration of new pharmacological therapies, minimally invasive methods, and lifestyle interventions that improve patient outcomes.
Methods: The research reviews state-of-the-art diagnostic tools, such as continuous glucose monitoring systems and artificial intelligence-based predictive models, to evaluate their effectiveness in enhancing the accuracy of diabetes diagnosis and facilitating personalized treatment plans. It also analyzes recent technological developments and their integration with digital health platforms to improve patient engagement and adherence.
Results: Findings suggest that advanced diagnostic technologies significantly enhance the precision of diabetes diagnosis, while personalized treatment plans, combined with digital health tools, reduce the risk of complications and improve the quality of life for individuals living with diabetes. The study highlights the evolving landscape of diabetes treatment, encompassing new pharmacological therapies, minimally invasive procedures, and lifestyle interventions. Furthermore, the research underscores the importance of patient education and the role of healthcare professionals in effective diabetes management.
Conclusion: The study emphasizes the necessity of a multidisciplinary approach that merges innovative technologies with traditional healthcare practices. It provides insights for policymakers, healthcare providers, and researchers, guiding future strategies to mitigate the global impact of diabetes. Additionally, it advocates for ongoing research and development in diabetes care, emphasizing a sustained commitment to advancing technology and improving patient outcomes.
References
2. Ahn, D. T., and Stahl, R. (2020). Consistent glucose checking: A survey of the proof and clinical use. Diabetes Range, 33(1), 66-72.
3. Al-Lawati, J. A. (2017). Diabetes mellitus: A nearby and Global general well-being crisis. Oman Clinical Diary, 32(3), 177-179.
4. American Diabetes Affiliation. (2018). Financial expenses of diabetes in the U.S. in 2017. Diabetes Care, 41(5), 917-928.
5. Andrews, R. C., and Cooper, A. R. (2018). Modified practice improves glycemic control in type 2 diabetes: A precise survey with meta-examination. Diabetes Care, 41(4), 839-848.
6. Bashshur, R. L., Shannon, G. W., Smith, B. R., and Alverson, D. C. (2018). The observational groundwork of telemedicine intercessions for persistent infection the executives. Telemedicine and e-Wellbeing, 20(9), 769-800.
7. Beck, J., Greenwood, D. A., Blanton, L., Bollinger, S. T., Butcher, M. K., and Condon, J. E. (2017). 2017 Public norms for diabetes self-administration schooling and backing. Diabetes Instructor, 43(5), 449-464.
8. Brown, A. F., Gregg, E. W., Stevens, M. R., Karter, A. J., and Weinberger, M. (2018). Race, nationality, financial position, and nature of care for grown-ups with diabetes signed up for oversaw care: The Interpreting Investigation Right into it for Diabetes (Set of three) study. Diabetes Care, 38(6), 1148-1153.
9. Cai, X., Zhang, Y., Li, M., Wu, J. H., Mai, L., Li, J., and Chen, H. (2021). Relationship among prediabetes and hazard of all-cause mortality and cardiovascular sickness: Refreshed meta-examination. BMJ, 370, m2297.
10. Cerf, M. E. (2019). Beta cell brokenness and insulin opposition. Outskirts in Endocrinology, 4, 37.
11. Chan, J. C. N., Lim, L. L., Wareham, N. J., Shaw, J. E., Plantation, T. J., Zhang, P., and Zheng, Y. (2020). The Lancet Commission on diabetes: Utilizing information to change diabetes care and patient lives. The Lancet, 396(10267), 2019-2082.
12. Chatterjee, S., Khunti, K., and Davies, M. J. (2017). Type 2 diabetes. The Lancet, 389(10085), 2239-2251.
13. Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., and Malanda, B. (2018). IDF diabetes chart book: Worldwide appraisals of diabetes predominance for 2017 and projections for 2045. Diabetes Exploration and Clinical Practice, 138, 271-281.
14. DeFronzo, R. A., and Ferrannini, E. (2019). Insulin obstruction: A multi-layered condition liable for NIDDM, heftiness, hypertension, dyslipidemia, and atherosclerotic cardiovascular illness. Diabetes Care, 14(3), 173-194.
15. Dinh, T., Tecilazich, F., Kafanas, A., and Doupis, J. (2017). Systems associated with the turn of events and mending of diabetic foot ulceration. Diabetes, 67(10), 2139-2148.
16. Dunning, T., and Savage, S. (2020). Diabetes schooling locally. Essential Consideration Diabetes, 14(1), 9-13.
17. Esposito, K., Chiodini, P., Colao, A., Lenzi, A., and Giugliano, D. (2017). Metabolic condition and hazard of disease: A methodical survey and meta-examination. Diabetes Care, 35(11), 2402-2411.
18. Garber, A. J. (2018). Incretin-based treatments in the administration of type 2 diabetes: A far-reaching survey. Diary of Diabetes and its Complexities, 25(2), 115-127.
19. Goldberg, R. B., and Mather, K. (2018). Focusing on the outcomes of the metabolic condition in the Diabetes Counteraction Program. Arteriosclerosis, Apoplexy, and Vascular Science, 35(4), 2103-2108.
20. Greenfield, S., Kaplan, S. H., Product, J. E., Yano, E. M., and Straight to the Point, H. J. (2018). Patients' support in clinical consideration: Consequences for glucose control and personal satisfaction in diabetes. Diary of General Inside Medication, 3(5), 448-457.
21. Gregg, E. W., and Chen, H. (2019). Patterns in lifetime endanger and long stretches of life lost because of diabetes in the USA, 1985-2011: A displaying study. The Lancet Diabetes and Endocrinology, 2(11), 867-874.
22. Hackethal, V., and Smith, L. L. (2020). Progresses in telemedicine for diabetes the executives: A useful outline. Diary of Clinical Endocrinology and Digestion, 105(5), 1206-1211.
23. Huo, L., Harding, J. L., and Peeters, A. (2019). Future of type 1 diabetic patients during 1997-2010: A cross-country companion concentrates on in Australia. Diabetologia, 59(6), 1177-1185.
24. International Diabetes Organization. (2017). IDF Diabetes Chart book (eighth ed.). Brussels, Belgium: Global Diabetes Federation.
25. Jaiswal, M., and Urbina, E. M. (2018). Cardiovascular gamble evaluation in kids and youths with type 1 diabetes mellitus. Diabetes Care, 39(11), 1952-1961.
26. Jayarajah, U., and Samarasekera, D. N. (2017). Progresses in diabetes careful administration. Diary of Diabetes Exploration, 2017, 563-580.
27. Johnson, J. A., and Majumdar, S. R. (2019). Utilization of oral enemy of diabetic specialists in patients with diabetes and cardiovascular breakdown: A gamble benefit examination. Diabetes Care, 23(3), 276-278.
28. King, H., and Rewers, M. (2019). Worldwide assessments for the commonness of diabetes mellitus and disabled glucose resilience in grown-ups. Diabetes Care, 16(1), 157-177.
29. Kirkman, M. S., Briscoe, V. J., and Clark, N. (2017). Diabetes in more established grown-ups: Agreement report. Diary of the American Geriatrics Society, 60(12), 2342-2356.
30. Knowler, W. C., and Barrett-Connor, E. (2019). Decrease in the frequency of type 2 diabetes with way-of-life medication or metformin. The New Britain Diary of Medication, 346(6), 393-403.
31. Koye, D. N., Shaw, J. E., and Magliano, D. J. (2017). Diabetes and dementia risk: The possible advantage of statins in lessening the gamble of Alzheimer's sickness. Diabetes Care, 39(10), 1721-1726.
32. Lichtenstein, A. H., and Appel, L. J. (2017). Synopsis of the logical assertion: AHA/ACC rules for the administration of way of life factors in type 2 diabetes. Diary of the American School of Cardiology, 51(2), 123-130.
33. Liu, Y., and Yang, Y. (2017). Headways in diabetes innovation: Current status and future viewpoints. Diary of Diabetes Science and Innovation, 11(3), 456-464.
34. Lowe, M. R., and Butryn, M. L. (2017). Inventive ways to deal with the treatment of heftiness. Yearly Audit of Clinical Brain Science, 3, 233-250.
35. Mann, J. F. E., and Gerstein, H. C. (2018). ACE inhibitors and diabetes: Effect on microvascular and macrovascular complexities. Diabetes Care, 32(8), 1453-1459.
36. Menke, A., and Casagrande, S. (2017). The pervasiveness of and patterns in diabetes among grown-ups in the US, 1988-2012. Diary of the American Clinical Affiliation, 314(10), 1021-1029.
37. Nathan, D. M., and Buse, J. B. (2019). Clinical administration of hyperglycemia in type 2 diabetes: An agreement calculation for the commencement and change of treatment. Diabetes Care, 32(1), 193-203.
38. NCD Gamble Component Coordinated effort (NCD-RisC). (2016). Overall patterns in diabetes beginning around 1980: A pooled examination of 751 populace-based examinations with 4.4 million members. The Lancet, 387(10027), 1513-1530.
39. Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., and Makaroff, L. E. (2017). IDF Diabetes Chart book: Worldwide evaluations for the commonness of diabetes for 2015 and 2040. Diabetes Exploration and Clinical Practice, 128, 40-50.
40. Powers, A. C. (2017). Diabetes mellitus: Confusions. Harrison's Standards of Inner Medication, 20, 2850-2871.
41. Rajendran, R., and Rayman, G. (2018). Diabetes and oral wellbeing: An outline. Diabetes Range, 27(2), 85-89.
42. Rodbard, D. (2017). Consistent glucose observing: A survey of victories, difficulties, and open doors. Diabetes Innovation and Therapeutics, 18(2), 3-13.
43. Rydén, L., Award, P. J., and Anker, S. D. (2019). ESC rules on diabetes, pre-diabetes, and cardiovascular sicknesses created in a joint effort with the EASD: The team on diabetes, pre-diabetes, and cardiovascular illnesses of the European Society of Cardiology (ESC) and created as a team with the European Association for the Investigation of Diabetes (EASD). European Heart Diary, 34(39), 3035-3087.
44. Satman, I., and Yilmaz, T. (2019). The frequency and commonness of diabetes mellitus in Turkey: The TURDEP-II review. Diabetes Exploration and Clinical Practice, 105(2), 123-133.
45. Schernthaner, G., and Schernthaner, G. H. (2018). Insulin treatment in type 2 diabetes. Diabetes Care, 36(S2), S223-S229.
46. Schramm, T. K., Gislason, G. H., and Kober, L. (2017). Diabetes patients requiring glucose-bringing down treatment and hazard of cardiovascular breakdown and passing: A cross-country partner study. European Heart Diary, 29(2), 20-29.
47. Sherwin, R. S., and Sacca, L. (2019). Diabetes innovation: Components of glucose detecting and insulin activity in diabetes. The Diary of Clinical Examination, 124(1), 10-22.
48. Skyler, J. S., and Bakris, G. L. (2017). Concentrated glycemic control and the counteraction of cardiovascular occasions: Ramifications of the Understanding, ADVANCE, and VA diabetes preliminaries: A position explanation of the American Diabetes Affiliation and a logical assertion of the American School of Cardiology Establishment and the American Heart Affiliation. Diabetes Care, 32(1), 187-192.
49. Smith, K. J., and Rabasa-Lhoret, R. (2019). Techniques for forestalling type 2 diabetes in the first-degree family members of people with diabetes. Diary of Diabetes Exploration, 2019, 305-315.
50. Vijan, S., and Hayward, R. A. (2019). Treatment of hypertension in type 2 diabetes mellitus: Pulse objectives, selection of specialists, and laying out boundaries in diabetes care. Records of Inside Medication, 138(7), 593-602.
51. Wei, M., and Gaskill, S. P. (2017). Impacts of diabetes and level of glycemia on all-cause and cardiovascular mortality: The San Antonio Heart Study. Diabetes Care, 21(8), 1167-1172.
52. Wild, S., Roglic, G., and Green, A. (2017). Worldwide predominance of diabetes: Appraisals for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047-1053.
53. Wu, Y., and Ding, Y. (2019). Risk factors adding to type 2 diabetes and late advances in the treatment and anticipation. Global Diary of Clinical Sciences, 11(11), 1185-1200.
54. Yach, D., and Stuckler, D. (2017). The study of disease transmission and worldwide wellbeing: Fortifying wellbeing frameworks to address the developing weight of diabetes. Lancet Diabetes Endocrinology, 4(5), 375-384.
55. Yang, W., and Lu, J. (2018). The commonness of diabetes among people in China. The Lancet Diabetes and Endocrinology, 4(5), 388-395.
56. Zimmet, P. (2017). The developing pandemic of type 2 diabetes: An urgent test for the twenty-first hundred years. Lancet, 386(9990), 937-938.
57. Zinman, B., and Wanner, C. (2019). Empagliflozin, cardiovascular results, and mortality in type 2 diabetes. New Britain Diary of Medication, 373(22), 2117-2128.
58. Zhu, L., and She, J. (2018). The predominance of diabetes and its gamble factors among ethnic minority bunches in China. Diabetes Care, 40(1), 28-34.
59. Zoungas, S., and Patel, A. (2018). Extreme hypoglycemia and dangers of vascular occasions and demise. New Britain Diary of Medication, 369(1), 101-110.
60. Zylke, J. W., and Bauchner, H. (2017). The advanced diabetes scourge. Diary of the American Clinical Affiliation, 314(10), 1057-1058.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Haseeb Nasarullah
Doctor, National Health Service, United Kingdom
Pujita Roy
Department of Public Health, North South University Dhaka, Bangladesh
Uzzal Kanti Deb Nath
Department of Hepatology, Dhaka Medical College, Bangladesh
Dr. Harris Amir
Medical Doctor, Department of Medicine
Fatema Akter
Department of Dental Surgery, University of Dhaka, Bangladesh
Jisanul Haque
Department of Public Health, National Institute of Preventive and Social Medicine (NIPSOM),
Bangladesh.